Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3′-kinase/protein kinase B/mammalian target of rapamycin pathway

References

• Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134:783–791.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer JClin. 2021;71:209–249.
   PubMed Web of Science ®Google Scholar
• Trojan J, Zangos S, Schnitzbauer AA. Diagnostics and treatment of hepatocellular carcinoma in 2016: standards and developments. Visc Med. 2016;32:116–120.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet (London,England). 2018;391:1301–1314.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Villanueva A, Lachenmayer A, et al. Advances in targeted therapies for hepatocellular carcinoma in the genomic era. Nat Rev Clin Oncol. 2015;12:408–424.
   PubMed Web of Science ®Google Scholar
• Makovich Z, Logemann J, Chen L, et al. Liver tumor ablation in difficult locations: microwave ablation of perivascular and subdiaphragmatic hepatocellular carcinoma. Clin Imaging. 2021;71:170–177.
   PubMed Web of Science ®Google Scholar
• Petrick JL, Kelly SP, Altekruse SF, et al. Future of hepatocellular carcinoma incidence in the United States forecast through 2030. J Clin Oncol. 2016;34:1787–1794.
   PubMed Web of Science ®Google Scholar
• Wilusz J, Shenk T. A uridylate tract mediates efficient heterogeneous nuclear ribonucleoprotein C protein-RNA cross-linking and functionally substitutes for the downstream element of the polyadenylation signal. Mol Cell Biol. 1990;10:6397–6407.
   PubMed Web of Science ®Google Scholar
• Köferle A, Schlattl A, Hörmann A, et al. Interrogation of cancer gene dependencies reveals novel paralog interactions of autosome and sex chromosome encoded genes. bioRxiv. 2021;9: 1–33.
   Google Scholar
• Hockert JA, Yeh HJ, MacDonald CC. The hinge domain of the cleavage stimulation factor protein CstF-64 is essential for CstF-77 interaction, nuclear localization, and polyadenylation. J Biol Chem. 2010;285:695–704.
   PubMed Web of Science ®Google Scholar
• Grozdanov PN, Masoumzadeh E, Latham MP, et al. The structural basis of CstF-77 modulation of cleavage and polyadenylation through stimulation of CstF-64 activity. Nucleic Acids Res. 2018;46:12022–12039.
   PubMed Web of Science ®Google Scholar
• Spies N, Burge CB, Bartel DP. 3’ UTR-isoform choice has limited influence on the stability and translational efficiency of most mRNAs in mouse fibroblasts. Genome Res. 2013;23:2078–2090.
   PubMed Web of Science ®Google Scholar
• Aragaki M, Takahashi K, Akiyama H, et al. Characterization of a cleavage stimulation factor, 3’ pre-RNA, subunit 2, 64 kDa (CSTF2) as a therapeutic target for lung cancer. Clin Cancer Res off J Am Assoc Cancer Res. 2011;17:5889–5900.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang JX, Luo JH, et al. CSTF2-Induced Shortening of the RAC1 3ʹUTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder. Cancer Res. 2018;78:5848–5862.
   PubMed Web of Science ®Google Scholar
• Zhang H, Xia P, Ma W, et al. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma. J Clini Transl Hepatol. 2021;9:635–646.
   PubMed Web of Science ®Google Scholar
• Chen J, Yu Y, Chen X, et al. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma. Cell Prolif. 2018;51(6):e12510.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Bamodu OA, Chang HL, Ong JR, et al. Elevated PDK1 expression drives PI3K/AKT/MTOR signaling promotes radiation-resistant and dedifferentiated phenotype of hepatocellular carcinoma. Cells. 2020;9:746.
   PubMed Web of Science ®Google Scholar
• Li A, Zhang R, Zhang Y, et al. BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway. Am J Transl Res. 2019;11:5573–5585.
   PubMed Web of Science ®Google Scholar
• Luo X, Cao M, Gao F, et al. YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition. Exp Hematol Oncol. 2021;10:35.
   PubMed Web of Science ®Google Scholar
• Yu Y, Zhao D, Li K, et al. E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway. Cell Death Dis. 2020;11:273.
   PubMed Web of Science ®Google Scholar
• Chen D, Wang Y, Lu R, et al. E3 ligase ZFP91 inhibits hepatocellular carcinoma metabolism reprogramming by regulating PKM splicing. Theranostics. 2020;10:8558–8572.
   PubMed Web of Science ®Google Scholar
• Condorelli DF, Privitera AP, Barresi V. Chromosomal density of cancer up-regulated genes, aberrant enhancer activity and cancer fitness genes are associated with transcriptional Cis-effects of broad copy number gains in colorectal cancer. Int J Mol Sci. 2019;20:4652.
   PubMed Web of Science ®Google Scholar
• Xia Z, Donehower LA, Cooper TA, et al. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3’-UTR landscape across seven tumour types. Nat Commun. 2014;5:5274.
   PubMed Web of Science ®Google Scholar
• Mao Z, Zhao H, Qin Y, et al. Post-Transcriptional dysregulation of microRNA and alternative polyadenylation in colorectal cancer. Front Genet. 2020;11:64.
   PubMed Web of Science ®Google Scholar
• Wang M, Huang S, Chen Z. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma. BMC Cancer. 2020;20(1):1136.
   PubMed Web of Science ®Google Scholar
• Shi Y, Manley JL. The end of the message: multiple protein-RNA interactions define the mRNA polyadenylation site. Genes Dev. 2015;29:889–897.
   PubMed Web of Science ®Google Scholar
• Nazeer FI, Devany E, Mohammed S, et al. p53 inhibits mRNA 3’ processing through its interaction with the CstF/BARD1 complex. Oncogene. 2011;30:3073–3083.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhang X, Lei W, et al. Genome-wide profiling reveals alternative polyadenylation of mRNA in human non-small cell lung cancer. J Transl Med. 2019;17:257.
   PubMed Web of Science ®Google Scholar
• Ren F, Zhang N, Zhang L, et al. Alternative polyadenylation: a new frontier in post transcriptional regulation. Biomarker Res. 2020;8:67.
   PubMed Web of Science ®Google Scholar
• Lachenmayer A, Alsinet C, Chang CY, et al. Molecular approaches to treatment of hepatocellular carcinoma. Dig Liver Dis. 2010;42(3):S264–72.
   PubMedGoogle Scholar
• Bortolotto LF, Barbosa FR, Silva G, et al. Cytotoxicity of trans-chalcone and licochalcone A against breast cancer cells is due to apoptosis induction and cell cycle arrest. Biomed Pharmacothe. 2017;85:425–433.
   PubMed Web of Science ®Google Scholar
• Hanker AB, Kaklamani V, Arteaga CL. Challenges for the clinical development of PI3K inhibitors: strategies to improve their impact in solid tumors. Cancer Discov. 2019;9:482–491.
   PubMed Web of Science ®Google Scholar
• He Y, Sun MM, Zhang GG, et al. Targeting PI3K/Akt signal transduction for cancer therapy. Signal Transduct Target Therapy. 2021;6:425.
   PubMed Web of Science ®Google Scholar
• Xue S, Zhou Y, Zhang J, et al. Anemoside B4 exerts anti-cancer effect by inducing apoptosis and autophagy through inhibition of PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Am J Transl Res. 2019;11:2580–2589.
   PubMed Web of Science ®Google Scholar
• Song XZ, Ren XN, Xu XJ, et al. LncRNA RHPN1-AS1 promotes cell proliferation, migration and invasion through targeting miR-7-5p and activating PI3K/AKT/mTOR pathway in hepatocellular carcinoma. Technol Cancer Res Treat. 2020;19:1533033820957023.
   Web of Science ®Google Scholar
• Sun L, Wang L, Chen T, et al. microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC. J Cell Mol Med. 2019;23:8292–8304.
   PubMed Web of Science ®Google Scholar